2022-12-29 · auto-analysis (draft)

Age Reversal Breakthroughs, FDA Approval, and Living Forever - David Sinclair’s AMA

The conversation discusses the challenges in bringing longevity therapies to market due to the FDA's rigorous approval process, while also highlighting recent breakthroughs in aging research and the potential for increased public pressure to speed up the approval process. This chunk discusses the launch of an age reversal X prize, the economic impact of extending healthspan, and personal insights from David Sinclair about his work and life.

▶ Watch on YouTube

Topics

Longevity Therapies Longevity ▶ 2:07
Longevity therapies are taking longer to come to market due to the rigorous drug development process and regulatory hurdles.
FDA Approval Process Longevity ▶ 4:05
The FDA's focus on safety and the high standards for drug approval are causing delays in bringing longevity therapies to market.
Breakthroughs in Aging Research Longevity ▶ 2:21
David Sinclair discusses breakthroughs in aging research, such as NAD boosters and reprogramming the eye to cure blindness.
Public Pressure for Faster Approval Longevity ▶ 8:13
There is a need for increased public pressure and dialogue to help the FDA find ways to make it easier to get drugs based on aging research approved.
Age Reversal Longevity ▶ 10:01
Discussion on the potential of using FDA-approved drugs for age reversal and the efforts to find dual-use treatments for diseases.
Personal Experience with Treatments Health ▶ 11:08
Peter Diamandis and David Sinclair discuss their personal preferences and experiences with experimental treatments.
Immortality and Technological Advancements Longevity ▶ 14:00
Peter Diamandis and David Sinclair debate on the concept of immortality and the role of technology in extending human lifespan.
Cryonics Longevity ▶ 17:00
Discussion on cryonics and its potential as a means to achieve immortality, with Peter Diamandis expressing skepticism and focusing on extending human lifespan through other means.
Anti-Aging Research Longevity ▶ 19:32
David Sinclair is recognized as a leading expert in anti-aging research.
X Prize for Age Reversal Other ▶ 20:00
Peter and David are co-chairs of a $101 million age reversal X prize.
Innovation and Economic Impact Economy ▶ 22:06
Adding one healthy year to a person's life could have an economic impact of $86 trillion in the US alone.
Public Engagement Other ▶ 23:00
David encourages people to follow him on social media and read his book for more information on his work and research.

Predictions made

open David Sinclair: A right to try strategy could be implemented to allow patients to try experimental drugs for aging-related diseases.
· due: unspecified · ▶ watch
“if you have a terminal disease or something that um doesn't have any current cure why not try something that is at least already shown in Phase One to be safe go for it”
Your call:
open Unknown: Peter Diamandis predicts that 150 years is achievable in many of their lifespans but not immortality.
· due: unspecified · ▶ watch
“Peter Diamandis: 150 is achievable in many of our lifespans but not immortality.”
Your call:
open Peter: The X prize will launch in the early part of 2023.
· due: 2023 · ▶ watch
“I hope to launch in the early part of 2023”
Your call:

Numbers that matter